Contractor Notice: Further extension to SSP05 and SSP009

Contractor Notice: Further extension to SSP05 and SSP009

March 30, 2021

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Fluoxetine 10mg tablets (SSP05) and Fluoxetine 40mg capsules (SSP009).

SSP05 for Fluoxetine 10mg tablets was previously expected to expire on 31st March 2021 but the end date has been further extended to 17th May 2021.

SSP009 for Fluoxetine 40mg capsules was previously expected to expire on 31st March 2021 but the end date has been further extended to 17th May 2021.

Please note: expiry dates of an SSP may be brought forward or extended, and the content may be amended at any time during the life of an SSP. Pharmacists should ensure they are using the latest version of an SSP before considering the supply of an alternative product.

Summary

SSP & Product Current expiry date
SSP05: Fluoxetine 10mg tablets This SSP has been varied – the revised end date for SSP05 is now 17th May 2021
SSP009: Fluoxetine 40mg capsules This SSP has been varied – the revised end date for SSP009 is now 17th May 2021

Current versions of SSPs can be found at: www.nhsbsa.nhs.uk/pharmacies-gp-practices-andappliance-contractors/serious-shortage-protocols-ssps

Also see Live SSPs

SSP05 recommendations

The SSP provides that the capsule formulation of Fluoxetine may be supplied against prescriptions for Fluoxetine 10mg tablets as follows:

For prescriptions (NHS or private) requesting: Supply permitted under SSP05:
Fluoxetine 10mg tablets Fluoxetine 10mg capsules

SSP009 recommendations

The SSP provides that two Fluoxetine 20mg capsules may be supplied against prescriptions for Fluoxetine 40mg capsules as follows:

For prescriptions (NHS or private) requesting: Supply permitted under SSP009:
Fluoxetine 40mg capsules 2 x Fluoxetine 20mg capsules

The pharmacist must exercise their professional judgement to ensure the alternative product is suitable for the patient.

Reimbursement and remuneration

Reimbursement is for the medicine supplied in accordance with the SSP and not the originally prescribed medicine. The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor:

  • One Single Activity fee (currently £1.27)
  • One SSP fee (£5.35)

Support in implementing the SSPs

The following resources have been developed to support pharmacy teams in using these protocols.

Submission of Serious Shortage Protocol (SSP) claims using EPS tokens

PSNC Briefing 002/21: Serious Shortage Protocol (SSP): SSP09 – Fluoxetine 40mg capsules

PSNC Briefing 015/20: Serious Shortage Protocols (SSPs): SSP05 – Fluoxetine 10mg tablets

Current versions of SSPs

Serious Shortage Protocols Operational Guidance

Serious Shortage Protocols Questions & Answers

PSNC’s Serious Shortage Protocols (SSPs) Endorsing Factsheet

PSNC Briefing 023/19: Serious Shortage Protocols – A guide for community pharmacy teams

Background information on SSPs

Further information on what SSPs are and when they may be used is available via the links below.

Serious Shortage Protocols (SSPs) on-demand webinar

Serious Shortage Protocols (SSPs) webpage



Posted in: , ,


More Latest News >